Answer
The most frequently reported adverse reactions to rezafungin acetate in clinical trials were hypokalaemia, pyrexia, anaemia and diarrhoea, all classified as very common.
Sources for this answer
- Rezzayo 200 mg powder for concentrate for solution for infusionNapp Pharmaceuticals Limited · emc · SmPC §4.8 Undesirable effects · Version 3Document updated
Sources checked